OVER-ALLOTMENT COMMON STOCK PURCHASE WARRANT northwest biotherapeutics, inc.Northwest Biotherapeutics Inc • August 9th, 2013 • Pharmaceutical preparations
Company FiledAugust 9th, 2013 IndustryTHIS OVER-ALLOTMENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after August ___, 2013 (the “Initial Exercise Date”) and on or prior to the close of business on August ___, 2014 (the “Termination Date”) but not thereafter, to subscribe for and purchase from NORTHWEST BIOTHERAPEUTICS, INC., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 9th, 2013 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 9th, 2013 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of August 8, 2013, between Northwest Biotherapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
NORTHWEST BIOTHERAPEUTICS, INC. PLACEMENT AGENT AGREEMENTPlacement Agent Agreement • August 9th, 2013 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 9th, 2013 Company Industry Jurisdiction